Prostaglandins in bone: bad cop, good cop?

Trends Endocrinol Metab. 2010 May;21(5):294-301. doi: 10.1016/j.tem.2009.12.004. Epub 2010 Jan 14.


Prostaglandins (PGs) are multifunctional regulators of bone metabolism that stimulate both bone resorption and formation. PGs have been implicated in bone resorption associated with inflammation and metastatic bone disease, and also in bone formation associated with fracture healing and heterotopic ossification. Recent studies have identified roles for inducible cyclooxygenase (COX)-2 and PGE(2) receptors in these processes. Although the effects of PGs have been most often associated with cAMP production and protein kinase A activation, PGs can engage an extensive G-protein signaling network. Further analysis of COX-2 and PG receptors and their downstream G-protein signaling in bone could provide important clues to the regulation of skeletal cell growth in both health and disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Bone Diseases / physiopathology
  • Bone Resorption / physiopathology*
  • Bone and Bones / metabolism*
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / physiology
  • Humans
  • Osteogenesis / physiology*
  • Prostaglandins / adverse effects
  • Prostaglandins / physiology*
  • RANK Ligand / physiology
  • Receptors, G-Protein-Coupled / physiology*
  • Receptors, Prostaglandin / physiology*


  • Prostaglandins
  • RANK Ligand
  • Receptors, G-Protein-Coupled
  • Receptors, Prostaglandin
  • Cyclooxygenase 2
  • Dinoprostone